Roche
This role involves spearheading the nonclinical safety strategy for Roche's innovative genetic medicine portfolio, focusing on ocular- and CNS-directed programs from early discovery through late-stage clinical development. The position requires collaborating with multidisciplinary scientists to drive decisions that safely accelerate groundbreaking medicines to patients. It serves as the primary toxicology representative on cross-functional drug development project teams across all stages.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1896
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roche.
136% above the average for this role
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago